Showing results (1591-1600 of 1,799) with videos related to

Sort By:
Pageof 180
Mabs|February 3, 2018
Practical approaches for overcoming challenges in heightened characterization of antibody-drug conjugates with new methodologies and ultrahigh-resolution mass spectrometryOlga V Friese, Jacquelynn N Smith, Paul W Brown, et al.
Mabs|May 25, 2022
An adapted consensus protein design strategy for identifying globally optimal biotherapeuticsYanyun Liu, Kenny Tsang, Michelle Mays, et al.
Mabs|July 9, 2021
Challenges of non-clinical safety testing for biologics: A Report of the 9th BioSafe European Annual General Membership MeetingThomas Kissner, Guenter Blaich, Andreas Baumann, et al.
Mabs|June 30, 2021
A T cell redirection platform for co-targeting dual antigens on solid tumorsLeonie Enderle, Karim H Shalaby, Maryna Gorelik, et al.
Mabs|April 7, 2020
Predicting Antibody Developability Profiles Through Early Stage Discovery ScreeningMarc Bailly, Carl Mieczkowski, Veronica Juan, et al.
Mabs|September 16, 2020
Targeted IgMs agonize ocular targets with extended vitreal exposureYvonne Chen, Maciej Paluch, Julie A Zorn, et al.
Mabs|January 5, 2021
Rational selection of building blocks for the assembly of bispecific antibodiesDanyang Gong, Timothy P Riley, Krzysztof P Bzymek, et al.
Mabs|January 5, 2021
Activity of murine surrogate antibodies for durvalumab and tremelimumab lacking effector function and the ability to deplete regulatory T cells in mouse models of cancerDarren J Schofield, Jennifer Percival-Alwyn, Mateusz Rytelewski, et al.
Mabs|January 6, 2021
Antibody-mediated delivery of LIGHT to the tumor boosts natural killer cells and delays tumor progressionMarco Stringhini, Jacqueline Mock, Vanessa Fontana, et al.
Mabs|December 21, 2020
Therapeutic blockade of CXCR2 rapidly clears inflammation in arthritis and atopic dermatitis models: demonstration with surrogate and humanized antibodiesMd Jahangir Alam, Liang Xie, Caroline Ang, et al.
Pageof 180